304 related articles for article (PubMed ID: 24433426)
1. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
2. Development of Ternary Amorphous Solid Dispersions Manufactured by Hot-Melt Extrusion and Spray-Drying─Comparison of
Trenkenschuh E; Blattner SM; Hirsh D; Hoffmann R; Luebbert C; Schaefer K
Mol Pharm; 2024 Mar; 21(3):1309-1320. PubMed ID: 38345459
[TBL] [Abstract][Full Text] [Related]
3. Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.
LaFountaine JS; Prasad LK; Brough C; Miller DA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):120-32. PubMed ID: 26729526
[TBL] [Abstract][Full Text] [Related]
4. Hypromellose acetate succinate based amorphous solid dispersions via hot melt extrusion: Effect of drug physicochemical properties.
Sarabu S; Kallakunta VR; Bandari S; Batra A; Bi V; Durig T; Zhang F; Repka MA
Carbohydr Polym; 2020 Apr; 233():115828. PubMed ID: 32059882
[TBL] [Abstract][Full Text] [Related]
5. A novel hot-melt extrusion formulation of albendazole for increasing dissolution properties.
Martinez-Marcos L; Lamprou DA; McBurney RT; Halbert GW
Int J Pharm; 2016 Feb; 499(1-2):175-185. PubMed ID: 26768722
[TBL] [Abstract][Full Text] [Related]
6. Alternative solvent-free preparation methods for felodipine surface solid dispersions.
Kerc J; Srcic S; Kofler B
Drug Dev Ind Pharm; 1998 Apr; 24(4):359-63. PubMed ID: 9876596
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive evaluation of polymer types and ratios in Spray-Dried Dispersions: Compaction, Dissolution, and physical stability.
Yu D; Nie H; Hoag SW
Int J Pharm; 2024 Jan; 650():123674. PubMed ID: 38061497
[TBL] [Abstract][Full Text] [Related]
8. HPMCAS-Based Amorphous Solid Dispersions in Clinic: A Review on Manufacturing Techniques (Hot Melt Extrusion and Spray Drying), Marketed Products and Patents.
Corrie L; Ajjarapu S; Banda S; Parvathaneni M; Bolla PK; Kommineni N
Materials (Basel); 2023 Oct; 16(20):. PubMed ID: 37895598
[TBL] [Abstract][Full Text] [Related]
9. Amorphous solid dispersion of a binary formulation with felodipine and HPMC for 3D printed floating tablets.
Mora-Castaño G; Millán-Jiménez M; Niederquell A; Schönenberger M; Shojaie F; Kuentz M; Caraballo I
Int J Pharm; 2024 Jun; 658():124215. PubMed ID: 38740104
[TBL] [Abstract][Full Text] [Related]
10. Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole.
Monschke M; Kayser K; Wagner KG
AAPS PharmSciTech; 2021 Jan; 22(1):44. PubMed ID: 33438107
[TBL] [Abstract][Full Text] [Related]
11. Concordance of vacuum compression molding with spray drying in screening of amorphous solid dispersions of itraconazole.
Dhumal G; Treffer D; Polli JE
Int J Pharm; 2024 Apr; 654():123952. PubMed ID: 38417729
[TBL] [Abstract][Full Text] [Related]
12. Strategies to improve the stability of amorphous solid dispersions in view of the hot melt extrusion (HME) method.
Al-Japairai K; Hamed Almurisi S; Mahmood S; Madheswaran T; Chatterjee B; Sri P; Azra Binti Ahmad Mazlan N; Al Hagbani T; Alheibshy F
Int J Pharm; 2023 Nov; 647():123536. PubMed ID: 37865133
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Amorphous Solid Dispersions of Spironolactone Prepared by Spray Drying and Electrospinning: The Influence of the Preparation Method on the Dissolution Properties.
Szabó E; Záhonyi P; Brecska D; Galata DL; Mészáros LA; Madarász L; Csorba K; Vass P; Hirsch E; Szafraniec-Szczęsny J; Csontos I; Farkas A; Van denMooter G; Nagy ZK; Marosi G
Mol Pharm; 2021 Jan; 18(1):317-327. PubMed ID: 33301326
[TBL] [Abstract][Full Text] [Related]
14. The effects of polymer carrier, hot melt extrusion process and downstream processing parameters on the moisture sorption properties of amorphous solid dispersions.
Feng X; Vo A; Patil H; Tiwari RV; Alshetaili AS; Pimparade MB; Repka MA
J Pharm Pharmacol; 2016 May; 68(5):692-704. PubMed ID: 26589107
[TBL] [Abstract][Full Text] [Related]
15. The potential of small-scale fusion experiments and the Gordon-Taylor equation to predict the suitability of drug/polymer blends for melt extrusion.
Forster A; Hempenstall J; Tucker ; Rades T
Drug Dev Ind Pharm; 2001 Jul; 27(6):549-60. PubMed ID: 11548862
[TBL] [Abstract][Full Text] [Related]
16. Carbamazepine/betaCD/HPMC solid dispersions. I. Influence of the spray-drying process and betaCD/HPMC on the drug dissolution profile.
Koester LS; Mayorga P; Bassani VL
Drug Dev Ind Pharm; 2003 Feb; 29(2):139-44. PubMed ID: 12648010
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Assessment of Cocrystal and Amorphous Solid Dispersion Printlets Developed by Hot Melt Extrusion Paired Fused Deposition Modeling for Dissolution Enhancement and Stability of Ibuprofen.
Mandati P; Nyavanandi D; Narala S; Alzahrani A; Vemula SK; Repka MA
AAPS PharmSciTech; 2023 Oct; 24(7):203. PubMed ID: 37783961
[TBL] [Abstract][Full Text] [Related]
18. An innovative carrier for the formulation of amorphous solid dispersion by hot-melt extrusion with no further downstream processes: a case study with indomethacin.
Lacerda SP; Del Confetto S; Haurie L; Bernard M; Faget S; Ré MI
Pharm Dev Technol; 2024 Feb; 29(2):131-142. PubMed ID: 38235570
[TBL] [Abstract][Full Text] [Related]
19. Characterization of solid dispersions of itraconazole and hydroxypropylmethylcellulose prepared by melt extrusion--Part I.
Verreck G; Six K; Van den Mooter G; Baert L; Peeters J; Brewster ME
Int J Pharm; 2003 Jan; 251(1-2):165-74. PubMed ID: 12527186
[TBL] [Abstract][Full Text] [Related]
20. Solid amorphous formulations for enhancing solubility and inhibiting Erlotinib crystallization during gastric-to-intestinal transfer.
Mugnier L; Espitalier F; Menegotto J; Bell S; Ré MI
Pharm Dev Technol; 2023 Sep; 28(7):697-707. PubMed ID: 37432652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
